• Drug Supply Health System Alert: Vitamin K Injection
• OPDP Notice No.18120 posted September 27, 2018 Prescription Forgery Alert
• Prescription Forgery Alert
• Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant with requirements for the manufacture of drug ingredients
• Advocacy at OPA
• It's Customer Service Week -- Take a Moment to Thank Our DIRC, PSN and CEA Teams
• Highlights in Professional Development​​
• And more

• Drug Supply Health System Alert: Fludarabine & Vinorelbine
• OPDP Notice No. 18114 posted September 20, 2018 ODB FORMULARY – EDITION NO. 43, Summary of Changes – September 2018
• OPDP Notice No. 18115 posted September 20, 2018 Notice from the Executive Officer: Funding of Glatect (glatiramer acetate) under the Ontario Drug Benefit Program
• OPDP Notice No. 18116 posted September 20, 2018 Notice from the Executive Officer: Funding of Renflexis (infliximab) under the Ontario Drug Benefit Program
• OPDP Notice No. 18117 posted September 21, 2018 Canada Post Labour Disruption - Ontario Drug Benefit Contingency Plan
• OPDP Notice No. 18118 posted September 25, 2018 Notice from the Executive Officer: Update on Claims Submission for Valved Holding Chambers through the Ontario Drug Benefit Program
• And more

• Drug Supply Health System Alert: Sodium Bicarbonate Injection USP 8.4%, 10 x 50mL vials
• Express Scripts Canada Correction Notice - Valsartan Recall
• OPDP Notice No. 18113 posted September 18, 2018 Prescription Forgery Alert
• OPA Launches Cannabis Tools for Use in Pharmacy Practice
• Highlights in Professional Development​​
• Ask the Practice Support Network
• OPA Secure Health Plan - Reduced Premium Changes

• OPDP Notice No. 18016A posted on September 7, 2018
• OPDP Notice No. 18110 posted on September 10, 2018 Notice from the Executive Officer: Availability and Funding of AUVI-Q® (Epinephrine Auto-Injectors)
• Highlights in Professional Development​​
• Ask the Customer Experience and Administration Team
• September Marketing Materials for Pharmacy Professionals
• Life Insurance v.s. Mortgage Insurance

• Health Canada Advisory -- Epinephrine Update
• OPDP Notice No. 18106 posted August 31, 2018 Prescription Forgery Alert
• Highlights in Professional Development​​
• OPA Term 10 Life Insurance Convertible Feature
• OPA Students - Take Our Survey
• Car Shopping?

• OPDP Notice No. 18103 posted August 23, 2018 ODB Formulary – Edition No. 43, Summary of Changes – August 2018
• OPDP Notice No. 18104 posted August 27, 2018 Prescription Forgery Alert
• Drug Supply Health System Alert: EpiPen Auto-Injector (0.3mg and 0.15mg)
• Drug Shortage Health System Alert: IV Fludarabine Update
• Highlights in Professional Development​​
• Ask the Customer Experience Team
• Naloxone for Back-to-School
• And more

• Health Canada - Recall Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution
• OPDP Notice No. 18100 posted August 15, 2018 Prescription Forgery Alert
• OPDP Notice No. 18101 posted August 20, 2018 Prescription Forgery Alert
• OPDP Notice No. 18102 posted August 20, 2018 Prescription Forgery Alert
• Drug Supply Alert - Docetaxel
• Drug Shortage Alert - Fludarabine
• Highlights in Professional Development​​
• Apply for Allied Health Professional Fund for Professional Development
• And more

• OPDP Notice No. 18098 posted August 13, 2018 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification to ODP Agencies
• OPDP Notice No. 18099 posted August 14, 2018 Notice from the Executive Officer: Claim Submission/Reversal and Special Authorization (Allergen) forms
• Recent Ontario Government Prompts OPA to Reinforce Request for Policy Changes to Allow Pharmacists to Dispense Medicinal Cannabis
• Highlights in Professional Development​​
• Apply for Allied Health Professional Fund for Professional Development Needs
• Ask the Customer Experience and Administration Team
• Is Your Financial Future in Order?
• OPA Members Save 10% on Pharmacist's Letter Canada